Morphometry of the coronary artery and heart microcirculation in
... vessels. The silver impregnation technique is most frequently applied for this purpose. It more effectively evaluates wall structure of the blood micro vessels. We used the coronary angiography method in some hearts to determine the great arteries such as RCA and left coronary artery (LCA) and its d ...
... vessels. The silver impregnation technique is most frequently applied for this purpose. It more effectively evaluates wall structure of the blood micro vessels. We used the coronary angiography method in some hearts to determine the great arteries such as RCA and left coronary artery (LCA) and its d ...
Guidelines for Perioperative Cardiovascular Evaluation for
... Based on scant evidence, preoperative preparation in intensive care unit may benefit certain high risk patients, particularly those with decompensated CHF. ...
... Based on scant evidence, preoperative preparation in intensive care unit may benefit certain high risk patients, particularly those with decompensated CHF. ...
Phase I clinical trial on intracoronary administration of Ad
... effective in both acute and chronic myocardial ischemia models and no apparent toxicity and mutation effects were observed in rat, minipig and rhesus. Its clinical application has been approved in China. The aim of this phase I clinical study is to evaluate the safety of Ad-HGF on individuals with c ...
... effective in both acute and chronic myocardial ischemia models and no apparent toxicity and mutation effects were observed in rat, minipig and rhesus. Its clinical application has been approved in China. The aim of this phase I clinical study is to evaluate the safety of Ad-HGF on individuals with c ...
Heart rate and atherosclerosis Jean-Claude Tardif *
... relative risk of sudden cardiac death of 3.46 by comparison with men whose HR was ,60 b.p.m., even after adjustment for age, use of tobacco, physical activity, diabetes, body mass index, blood pressure, cholesterol, parental history of sudden death or myocardial infarction, and exercise duration. He ...
... relative risk of sudden cardiac death of 3.46 by comparison with men whose HR was ,60 b.p.m., even after adjustment for age, use of tobacco, physical activity, diabetes, body mass index, blood pressure, cholesterol, parental history of sudden death or myocardial infarction, and exercise duration. He ...
Perioperative Management of the Cardiac Patient
... surgery. Ann Pharmacother. 2001;1075-84. S Mussa, et al. Radial artery conduits for coronary artery bypass grafting: current ...
... surgery. Ann Pharmacother. 2001;1075-84. S Mussa, et al. Radial artery conduits for coronary artery bypass grafting: current ...
Safety of coronary Computed Tomography Angiography for
... vessel lumen and wall are identified, there are a larger number of plaques that, because of their non-obstructive nature, are not shown on angiography (since this method is mainly a luminogram)10-12. In the study conducted by Litt et al.9, patients with chest pain and low to intermediate likelihood ...
... vessel lumen and wall are identified, there are a larger number of plaques that, because of their non-obstructive nature, are not shown on angiography (since this method is mainly a luminogram)10-12. In the study conducted by Litt et al.9, patients with chest pain and low to intermediate likelihood ...
LEFT ATRIAL MYXOMA WITH CORONARY ARTERY DISEASE: AN UNEXPECTED PREOPERATIVE FINDING m
... villous, it could have been the source of right coronary artery embolization with subsequent recanalization. This was seen as QS waves in the inferior wall leads in the ECG as well as an akinetic segment on TTE. But, coronary angiography that was performed a few days later revealed a normal right co ...
... villous, it could have been the source of right coronary artery embolization with subsequent recanalization. This was seen as QS waves in the inferior wall leads in the ECG as well as an akinetic segment on TTE. But, coronary angiography that was performed a few days later revealed a normal right co ...
Slajd 1
... ß-Blockers in patients with previous MI (level of evidence: A) or without previous MI (level of evidence: B) Low-density lipoprotein cholesterol–lowering therapy with a statin (level of evidence: A) ACE inhibitor (level of evidence: A) ...
... ß-Blockers in patients with previous MI (level of evidence: A) or without previous MI (level of evidence: B) Low-density lipoprotein cholesterol–lowering therapy with a statin (level of evidence: A) ACE inhibitor (level of evidence: A) ...
Welcome to the Cardiac Rehabilitation Department
... A fatty material made mainly in the body by the liver, it is important for cell function and for the production of vital chemicals. Too much cholesterol in the blood (hypercholesterolaemia or hyperlipidaemia) can increase the risk of developing Cardiovascular Disease. ...
... A fatty material made mainly in the body by the liver, it is important for cell function and for the production of vital chemicals. Too much cholesterol in the blood (hypercholesterolaemia or hyperlipidaemia) can increase the risk of developing Cardiovascular Disease. ...
The Changing Paradigm of Renal Artery Stenosis
... In the absence of significant differences in long-term outcome measures, given the rates of restenosis following simple balloon angioplasty and the complications and costs of surgical intervention, it would seem reasonable to consider angioplasty with stenting as the revascularisation procedure of c ...
... In the absence of significant differences in long-term outcome measures, given the rates of restenosis following simple balloon angioplasty and the complications and costs of surgical intervention, it would seem reasonable to consider angioplasty with stenting as the revascularisation procedure of c ...
.I Summary and Future Perspectives Willem G.van Dockum ____________________________
... gradient reduction and relief of symptoms, compared to a second group with exclusively right-sided location of septal infarction. This is important feed-back for the interventional cardiologist to optimize this promising therapeutic option in ...
... gradient reduction and relief of symptoms, compared to a second group with exclusively right-sided location of septal infarction. This is important feed-back for the interventional cardiologist to optimize this promising therapeutic option in ...
Drug-coated balloon treatment for lower extremity vascular disease
... to physiological torsion of the femoral artery potentially resulting in either restenosis or vessel wall damage.5 In the below-the-knee (BTK) arterial distribution, long dedicated stents are not available. In-stent restenosis (ISR) is a major problem and complications related to lower extremity sten ...
... to physiological torsion of the femoral artery potentially resulting in either restenosis or vessel wall damage.5 In the below-the-knee (BTK) arterial distribution, long dedicated stents are not available. In-stent restenosis (ISR) is a major problem and complications related to lower extremity sten ...
Angiotensin-Converting Enzyme Inhibitors in Patients
... (APRES [Angiotensin-converting Enzyme Inhibition Post Revascularization Study]).14 In both HOPE and EUROPA, measurement of LVEF was not a prerequisite for inclusion. However, subsequent analyses in patients in whom LVEF had been determined showed that in both trials LVEF was greater than 0.40 in mor ...
... (APRES [Angiotensin-converting Enzyme Inhibition Post Revascularization Study]).14 In both HOPE and EUROPA, measurement of LVEF was not a prerequisite for inclusion. However, subsequent analyses in patients in whom LVEF had been determined showed that in both trials LVEF was greater than 0.40 in mor ...
Aspirin
... drug-eluting stent placement: The American College of Chest Physicians recommends the use of 75-325 mg once daily (in combination with clopidogrel) for 1 month (BMS) or 3-6 months (dependent upon DES type) followed by 75-100 mg once daily (in combination with clopidogrel) for up to12 months. For pat ...
... drug-eluting stent placement: The American College of Chest Physicians recommends the use of 75-325 mg once daily (in combination with clopidogrel) for 1 month (BMS) or 3-6 months (dependent upon DES type) followed by 75-100 mg once daily (in combination with clopidogrel) for up to12 months. For pat ...
this PDF file - International Journal of Research in
... strategies at higher rates compared with older patients when admitted with ACS.7,21,22, 28,37,38 Most of published studies of outcome in young patients limited their data to the in-hospital adverse events with a mortality rate that ranged between 1.6% and 3%.11,17 These rates were not necessarily lo ...
... strategies at higher rates compared with older patients when admitted with ACS.7,21,22, 28,37,38 Most of published studies of outcome in young patients limited their data to the in-hospital adverse events with a mortality rate that ranged between 1.6% and 3%.11,17 These rates were not necessarily lo ...
GBMC Peri-Operative Medication Reference 4.12.16
... Continue Treatment up to and including day of surgery26 Discontinue 7 days prior to non cardiovascular surgery when being used for primary prevention of stroke and ACS27 *Continue aspirin in patients undergoing carotid endarterectomy, recent coronary stent (Bare Metal Stent <30 days, Drug-Eluting St ...
... Continue Treatment up to and including day of surgery26 Discontinue 7 days prior to non cardiovascular surgery when being used for primary prevention of stroke and ACS27 *Continue aspirin in patients undergoing carotid endarterectomy, recent coronary stent (Bare Metal Stent <30 days, Drug-Eluting St ...
myocardial infarction - the basic science behind an
... Research has indicated that BMI may not be the most accurate indicator of cardiovascular risk, with the INTERHEART study advocating the use of waist-to-hip ratio in assessing someone’s risk14. BMI was found to be a poor indicator in those with a history of hypertension, and in certain ethnic groups ...
... Research has indicated that BMI may not be the most accurate indicator of cardiovascular risk, with the INTERHEART study advocating the use of waist-to-hip ratio in assessing someone’s risk14. BMI was found to be a poor indicator in those with a history of hypertension, and in certain ethnic groups ...
minimally invasive cardiac surgery
... performed in the late 1950s on beating heart without using CPB.2 Kolesov from Russia reported the technique of mammary artery- coronary artery anastomosis on beating heart for treatment of coronary artery disease3 . Later on Favaloro in U.S.A. popularised the technique of direct myocardial revascula ...
... performed in the late 1950s on beating heart without using CPB.2 Kolesov from Russia reported the technique of mammary artery- coronary artery anastomosis on beating heart for treatment of coronary artery disease3 . Later on Favaloro in U.S.A. popularised the technique of direct myocardial revascula ...
Investigating stable chest pain of suspected cardiac origin
... Hospital, London. To suggest a topic for this series, please email us at [email protected] ...
... Hospital, London. To suggest a topic for this series, please email us at [email protected] ...
Clinical and Angiographic Correlation of Chest Pain with Right
... (p=0.001) among males (88.64%) compared to females (33.33%). Similarly, all the patients (100%) who presented with age more than 60 years and maximum patients who were aged between 45 to 60 years had coronary artery disease (68.42%) compared to 60% and 50% of the patients who were aged between 31 to ...
... (p=0.001) among males (88.64%) compared to females (33.33%). Similarly, all the patients (100%) who presented with age more than 60 years and maximum patients who were aged between 45 to 60 years had coronary artery disease (68.42%) compared to 60% and 50% of the patients who were aged between 31 to ...
GCE AS/A level 1661/01-A APPLIED SCIENCE
... Procedures used to treat blocked arteries 1. Coronary angioplasty ...
... Procedures used to treat blocked arteries 1. Coronary angioplasty ...
ISHEMIC CONDITIONING - EVIDENCE REVIEW DR SANMATH
... 333 patients with first STEMI for primary PCI Randomised to RIC vs control. Primary endpoint was major adverse cardiac and cerebrovascular events (MACCE)—a composite of all-cause mortality, myocardial infarction, readmission for heart failure, and ischaemic stroke/transient ischaemic attack. Media ...
... 333 patients with first STEMI for primary PCI Randomised to RIC vs control. Primary endpoint was major adverse cardiac and cerebrovascular events (MACCE)—a composite of all-cause mortality, myocardial infarction, readmission for heart failure, and ischaemic stroke/transient ischaemic attack. Media ...
Critical Limb Ischemia Compendium (CLIC
... limitation of endovascular therapies (balloon angioplasty [BA] and bare metal stents [BMS]) for femoropopliteal arterial lesions is the high rate of early restenosis requiring repeat revascularization.5 Achieving Patency in Arterial Disease The 1-year patency rates following BA alone are reported to ...
... limitation of endovascular therapies (balloon angioplasty [BA] and bare metal stents [BMS]) for femoropopliteal arterial lesions is the high rate of early restenosis requiring repeat revascularization.5 Achieving Patency in Arterial Disease The 1-year patency rates following BA alone are reported to ...
Drug-eluting stent
A drug-eluting stent (DES) is a peripheral or coronary stent (a scaffold) placed into narrowed, diseased peripheral or coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombi), could otherwise block the stented artery, a process called restenosis. The stent is usually placed within the peripheral or coronary artery by an interventional cardiologist or interventional radiologist during an angioplasty procedure.Drug-eluting stents in current clinical use were approved by the FDA after clinical trials showed they were statistically superior to bare-metal stents for the treatment of native coronary artery narrowings, having lower rates of major adverse cardiac events (usually defined as a composite clinical endpoint of death + myocardial infarction + repeat intervention because of restenosis). The first drug-eluting stents to be approved in Europe and the U.S. were coated with paclitaxel or an mTOR inhibitor, such as sirolimus.